MPPE1 and breast cancer: This new cDC1 signature provides a powerful means to demonstrate a positive association of cDC1 with patient survival in several human cancers, including metastatic melanoma, breast cancer, head and neck squamous cell carcinoma, and lung adenocarcinoma.